12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CTP-499: Phase I started

Concert began a U.S. Phase I trial to evaluate single ascending-doses of oral CTP-499 in healthy...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >